Researchers who started a ketamine and esketamine service for patients with depression and suicidal thoughts discuss lessons learned. Interest in the use of ketamine for the treatment of ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not ...

At 7 days postpartum, esketamine was associated with significantly lower depressive symptom prevalence vs. placebo. No differences in depression incidence were noted between groups at 14 ...

17 In patients with treatment-resistant depression, reductions in depressive symptoms and in the risk of relapse were observed with esketamine nasal spray as compared with placebo nasal spray when ...

A nasal spray version of esketamine was more effective for depression that is resistant to treatment than a more commonly used drug, research published Wednesday in The New England Journal of ...

and anxiety in patients with treatment-resistant depression (TRD), new research suggests. Results from a retrospective chart review analysis, which included more than 400 participants with TRD ...

Fast-acting antidepressants can work in hours to help you feel better if you have depression or suicidal thoughts. The FDA in 2019 approved the first, a nasal spray called esketamine for treatment ...

Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression, a randomized, double-blind trial found. Among 379 participants in the efficacy ...

A nasal spray formulation is authorized under certain conditions for the treatment of resistant depression. Several studies have shown that small doses of esketamine improve analgesia and reduce ...

Esketamine targets the glutamate neurotransmitter pathway, offering a novel mechanism for treatment-resistant depression. The treatment is available through a Risk Evaluation and Mitigation ...

A single low dose injection of esketamine given immediately after childbirth reduces major depressive episodes in individuals with depressive symptoms during pregnancy (prenatal depression), finds ...

A 67-year-old woman with a history of obesity, chronic low back pain, and recurrent episodes of major depression presents ... and ketamine or esketamine therapy) when depressive symptoms are ...